Over 100 people being investigated for vape offences, say MOH and HSA
In a joint statement, MOH and HSA said 18 individuals are facing charges in court for offences under the Tobacco (Control of Advertisements and Sale) Act involving the sale, advertising or import of e-vaporisers.
As at Aug 14, five people have been charged over the sale or importation of etomidate-laced e-vaporisers. HSA is also investigating about 65 cases involving the possession, sale or importation of etomidate-laced e-vaporisers.
Another 100 are under investigation for offences involving non-etomidate e-vaporisers under the Tobacco (Control of Advertisements and Sale) Act, said the authorities.
They said: 'MOH and HSA have been intensifying enforcement actions against etomidate-laced e-vaporiser offences in Singapore.'
Under the Poisons Act, those convicted of possessing, importing or selling pods containing etomidate can be jailed for up to two years and/or fined up to $10,000.
MOH and HSA said etomidate will soon be classified as a Class C controlled drug under the Misuse of Drugs Act.
Offenders caught using etomidate-laced e-vaporisers will be subject to mandatory supervision and rehabilitation. Repeat offenders are liable to be prosecuted and subject to jail for at least a year.
More severe penalties apply to those selling, distributing or importing these devices, including imprisonment of up to 20 years and caning.
'Users of e-vaporisers, particularly those consuming etomidate, are strongly urged to cease consumption immediately,' said MOH and HSA.
The increase in enforcement numbers comes after The Straits Times launched its anti-vaping campaign called Vaping: The Invisible Crisis on July 13.
Etomidate is meant for use only during medical procedures. When vaped, etomidate enters the lungs directly, potentially triggering spasms, breathing difficulties, seizures and even psychosis.
If etomidate is listed as a Class C drug, abusers can be subjected to supervision and mandatory participation in a rehabilitation programme or committed to drug rehabilitation centres, similar to what drug abusers undergo.
Under current laws, possessing, using or buying vapes carries a maximum fine of $2,000.
Those found in possession of or using pods containing etomidate can be jailed for up to two years and fined up to $10,000.
The measures listed in the MOH-HSA joint statement are among the latest the authorities have taken to tackle the vape scourge in Singapore.
On Aug 13, HSA said it was working with Hong Kong's Department of Health (DOH) to tackle vaping by exchanging information and expertise with each other. HSA signed a memorandum of understanding with the DOH for cooperation in healthcare regulatory matters involving health products.
Also on Aug 13, ST reported HSA had recently advertised job openings for investigators specifically to crack down on Kpods. As at Aug 14, more than 500 people have applied for the job.
The public can report vaping offences to the Tobacco Regulation Branch on 6684-2036 or 6684-2037 from 9am to 9pm daily, or online at www.go.gov.sg/reportvape
Those who need help to quit vaping can join the Health Promotion Board's I Quit programme by calling the QuitLine on 1800-438-2000.
The authorities have said those who voluntarily seek support to quit vaping will not face any penalties for doing so.
Source: The Straits Times © SPH Media Limited. Permission required for reproduction
Discover how to enjoy other premium articles here
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Aging Can Spread Through Your Body Via a Single Protein, Study Finds
Take note of the name: ReHMGB1. A new study pinpoints this protein as being able to spread the wear and tear that comes with time as it quietly travels through the bloodstream. This adds significantly to our understanding of aging. Short for reduced high mobility group box 1, ReHMGB1 triggers senescence in cells, permanently disabling them. It doesn't just do this locally; it can send damaging signals throughout the body, particularly in response to injuries or disease. "An important question in aging research is why senescent cells increase with age," write the study authors, led by researchers from the Korea University College of Medicine. Related: The team says their findings could help develop ways to keep us healthier for longer. If we can block or control this protein's signals, it might slow the cascade of cellular decline that comes with age. "This study reveals that aging signals are not confined to individual cells but can be systemically transmitted via the blood, with ReHMGB1 acting as a key driver," says Korea University biomedical engineer Ok Hee Jeon. The researchers were able to identify ReHMGB1 as a critical messenger passing on the senescence signal by analyzing different types of human cells grown in the lab and conducting a variety of tests on mice. When ReHMGB1 transmission was blocked in mice with muscle injuries, muscle regeneration happened more quickly, while the animals showed improved physical performance, fewer signs of cellular aging, and reduced systemic inflammation. The next step would be to see how this process could be disrupted, and this particular type of aging signal kept more localized – so the health conditions that come with old age might not be as damaging. "By blocking this pathway, we were able to restore tissue regenerative capacity, suggesting a promising strategy to treat aging-related diseases," says Jeon. This process is only one contributor to aging out of many, but the signals that ReHMGB1 spreads are particularly important in terms of our bodies becoming dysfunctional over time and less able to carry out repairs. It's also worth bearing in mind the useful functions of ReHMGB1 in the body: alerting our biological systems to damage and indicating that repairs are needed. Any kind of intervention will have to take that into consideration. We know that, generally speaking, populations are living for longer than ever before, and that's putting both our bodies and scientific research into uncharted territory. The various routines built into our cells must continue to function when years ago our bodies would have long given up. Related: From where we live to the genetics we're born with, there are many contributors to aging and lifespan. By learning more about how these work, we'll be better able to manage them – and perhaps extend life further. "Building on current research in these areas will be essential to understanding the therapeutic potential of redox-sensitive HMGB1 in aging-related diseases and its role as a systemic mediator of senescence," write the researchers in their published paper. The research has been published in Metabolism. Related News New Genetic Test Predicts Children With Future Risk of High BMI This Diet Helps Lower Dementia Risk, And We May Finally Know Why A Signal of Future Alzheimer's Could Hide in The Way You Speak Solve the daily Crossword
Yahoo
16 hours ago
- Yahoo
Are mangoes good for diabetes? Indian studies challenge conventional wisdom
As summer sweeps across India, one of the most common questions a leading Mumbai-based diabetologist hears from his patients is: "Can I eat mangoes?" "Mangoes, with their rich sweetness and diverse varieties, are a staple of Indian summers, and it's understandable why people want to indulge," says Rahul Baxi. However, this simple question, he says, comes loaded with misconceptions - ranging from the belief that mangoes should be strictly avoided, to the opposite extreme where some think eating mangoes in excess might "reverse diabetes". The reality lies somewhere in between, but the confusion doesn't end with the season. "In fact, many patients return for follow-up visits post-mango season, often with elevated glucose levels, and sometimes, the culprit may just be overindulgence in this beloved fruit," says Dr Baxi. This constant dilemma has left many people with diabetes wary of the "king of fruits". Yet, new research suggests that mangoes might not be the villain they're sometimes made out to be. Two new Indian clinical trials are turning conventional dietary wisdom on its head, suggesting that controlled mango consumption instead of carbohydrates (in the form of bread) may actually improve blood sugar and metabolic health in people with type 2 diabetes. Type 1 diabetes occurs when the pancreas produces little or no insulin, while in type 2, the body becomes resistant to insulin's effects. Type 2 diabetes makes up over 90% of global cases, according to the International Diabetes Federation (IDF). It's the eighth leading cause of disease burden worldwide, projected to rank second by 2050. Though not fully understood, it's strongly linked to excess weight, age, ethnicity and family history. In India, an estimated 77 million adults have type 2 diabetes, while nearly 25 million are prediabetic and at high risk of developing the condition, according to the World Health Organization. Yet amidst the challenges, new findings offer a surprising ray of hope - especially for mango lovers. A pilot study soon to appear in the European Journal of Clinical Nutrition and involving 95 participants found that three popular Indian mango varities - Safeda, Dasheri and Langra - produced similar or lower glycemic responses than white bread over two hours of glucose testing. (A glycemic response is how quickly and how much a food raises blood sugar levels after eating.) Continuous glucose monitoring of people with and without type 2 diabetics over three days showed that, in participants with diabetes, post-meal sugar fluctuations were significantly smaller after eating a mango. This low fluctuation glycemic response could be beneficial to the body in the long run, researchers say. "Mangoes are a much-loved fruit and maligned for its possible glucose and weight-elevating effects," said Dr Sugandha Kehar, first author of both studies. "These studies show that within prescribed diets, consumption of mangoes are not detrimental to blood glucose and may even be beneficial," A second, eight-week randomised trial published in the Journal of Diabetes & Metabolic Disorders - conducted at Delhi's Fortis C-DOC with Indian Council of Medical Research funding - has reinforced the findings. Thirty-five adults with type 2 diabetes who replaced their breakfast bread with 250g of mango saw improvements in fasting glucose, haemoglobin A1C test (HbA1c) which measures average blood sugar levels, insulin resistance, weight, waist circumference and HDL cholesterol. These markers are key indicators of diabetes control and overall metabolic health. "We showed the benefits of small doses of mangoes in place of carbohydrates (bread) in breakfast in two detailed studies for the first time, laying to rest all speculations regarding adverse metabolic effects of its consumption," says Prof Anoop Misra, senior author and study lead. "But the key is moderation and clinical supervision - this is not a licence for unlimited mango feasts." I asked Prof Misra what eating mangoes in moderation meant. "If your daily limit is 1,600 calories, any calories from mango should be part of that total, not extra. A 250g mango - about one small fruit - has roughly 180 calories. As in the study, you'd replace an equivalent amount of carbs with mango to get the same results," he told me. Dr Baxi says he tells his patients something similar. "If glucose levels are under control, I do allow and even encourage my patients to enjoy mangoes in limited quantities - about half portion which gives 15g carbohydrates - once or twice a day." Dr Baxi tells his patients: portion control is key - mangoes should be eaten between meals, not as dessert. Pair them with protein or fibre, and avoid combining with other carbs or sugary forms, such as juices and milkshakes. Beyond its metabolic impact, the mango occupies a far larger place in Indian life - a fruit that opens doors both literally and figuratively, carrying cultural, social and even diplomatic significance. "Mango diplomacy" is a familiar phrase across the subcontinent, where carefully chosen crates of the fruit can grease political deals, strengthen alliances or smooth over tense negotiations. Mango festivals pop up across Indian cities, celebrating the fruit's cultural and economic significance. The fruit is, at once, a favourite indulgence and a quietly powerful social currency. "Most Indians have a personal favourite mango and parochial regional loyalties have long fuelled heated ranking debates," says Pushpesh Pant, a Delhi-based historian and culinary expert. "Good mangoes are not just to be eaten; they are adornments like jewellery. The rules of the mango push the best produce towards those willing to pay the highest price," writes Sopan Joshi in Mangifera indica: A Biography of the Mango, a magisterial account of the fruit and its admirers. There are more than 1,000 varieties of mango grown in India. Joshi writes India's mangoes vary by region: northern and eastern varieties like Langra, Dasheri, Chausa and Himsagar are intensely sweet, while southern types offer a subtle sweet-sour flavour. The Alphonso of western India owes its signature taste to a unique balance of sugar and acid. So central is the fruit to Indian life that the calendar year itself often begins with the mango flowering. Poet Ghalib called the mango a "a sealed glass of honey", and hundreds of books have been written celebrating its allure. Part indulgence, part icon, the mango continues to delight and inspire - now with a surprising nod from science.
CNN
19 hours ago
- CNN
Climate change is making things even worse for the poorly housed
Climate change is making Hong Kong's summers hotter. Yet tens of thousands of residents remain sardined into homes smaller than a parking space, where staying cool is a luxury few can afford as the climate warms. In small, enclosed spaces with little ventilation or cooling, indoor temperatures can soar past 100°F (37.7°C), posing serious health risks for the city's most vulnerable.
